8081524 (CDM) by state — Price Transparency

CDM · across United States

8081524 — Natalizumab (Tysabri) 300mg/15ml Vial

State-by-state median negotiated rates. Lower bars are cheaper states; the range bar shows the IQR (25th to 75th percentile within each state).

$23,531 National median

$21,919 – $26,161 IQR (p25 – p75)

1 hospitals filing

1 states

View hospital-by-hospital → Raw rate rows →

Estimate your cost

What would you pay?

Plug in your deductible, what you've already spent against it, your OOP-max, and your coinsurance %. We'll math the rest. Math reference: methodology.

This estimate runs on the hospital’s facility charge only. The surgeon’s and anesthesiologist’s fees are billed separately and aren’t in this number — your EOB shows your complete total.

I am… Annual deductible (assumed — typical plan) Already spent this year

Checked your insurer’s portal? Enter your remaining deductible and out-of-pocket max above/below and leave “already spent” at 0.

Out-of-pocket max (assumed — typical plan) Coinsurance % (after deductible)

Loading estimate…

Median negotiated rate, by state

Ranked by typical (median) negotiated price. Hover for state-level IQR.

Median negotiated rate by state for 8081524 (CDM), with interquartile range
State	Median	p25	p75
KS	$23,531	$21,919	$26,161

Sortable, filterable data table. Use the column headers to sort, the filter row to narrow results.
State	Median	p25	p75	Min	Max	Hospitals	Payers	Rates

KS	$23,531	$21,919	$26,161	$15,555	$28,848	1 ⚠ thin data	6	7